Arun Sadhanandham
About Arun Sadhanandham
Data last updated:
Arun Sadhanandham is a Nominee Director at Entero Healthcare Solutions Limited (since 2020), Nominee Director at Blue Sapphire Healthcares Private Limited (since 2023) and Director at Lifewell Diagnostics Private Limited (since 2022). The companies operate in Pharma, Education and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹7,125 Cr; the largest is Entero Healthcare Solutions Limited at ₹6,610 Cr (FY 2026). Earlier, Arun Sadhanandham was a Nominee Director at Suraksha Diagnostic Limited (2023–2025) and Director at H S Pathology Private Limited (2022–2024) and 17 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Entero Healthcare Solutions Limited L74999HR2018PLC072204 | Nominee Director | 25 Aug 2020 | 2018 | ₹6,610 Cr (FY 2026) | Active |
 Blue Sapphire Healthcares Private Limited U74999DL2007PTC159674 | Nominee Director | 20 Nov 2023 | 2007 | ₹490 Cr (FY 2025) | Active |
 Lifewell Diagnostics Private Limited U85100TN2022PTC150858 | Director | 09 May 2022 | 2022 | ₹24.02 Cr (FY 2023) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Suraksha Diagnostic Limited L85110WB2005PLC102265 | Nominee Director | 20 Nov 2023 | 2005 | ₹12.21 Cr (FY 2025) | Active |
 H S Pathology Private Limited U74990TN2010PTC169600 | Director | 05 Sep 2022 | 2010 | ₹12.01 Cr (FY 2024) | Amalgamated |
| Chethana Pharma Private Limited U51909KA2019PTC123150 | Director | 06 Feb 2020 | 2019 | ₹232 Cr (FY 2025) | Active |
| Chethana Healthcare Solutions Private Limited U51909KA2019PTC122804 | Director | 06 Feb 2020 | 2019 | ₹50.30 Cr (FY 2025) | Active |
 Novacare Healthcare Solutions Private Limited U51900MH2018PTC309987 | Director | 10 Jun 2019 | 2018 | ₹527 Cr (FY 2025) | Active |
 R S M Pharma Private Limited U85110KA1989PTC009974 | Director | 10 Jun 2019 | 1989 | ₹363 Cr (FY 2025) | Active |
| Galaxystar Pharma Distributors Private Limited U51909MH2018PTC314815 | Director | 10 Jun 2019 | 2018 | ₹358 Cr (FY 2025) | Active |
 Getwell Medicare Solution Private Limited U52310KL2018PTC055604 | Director | 10 Jun 2019 | 2018 | ₹225 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Arun Sadhanandham
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Arun Sadhanandham
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Arun Sadhanandham
Arun Sadhanandham currently holds 3 directorships: Entero Healthcare Solutions Limited (Nominee Director, since 25 Aug 2020, revenue ₹6,610 Cr (FY 2026)); Blue Sapphire Healthcares Private Limited (Nominee Director, since 20 Nov 2023, revenue ₹490 Cr (FY 2025)); Lifewell Diagnostics Private Limited (Director, since 09 May 2022, revenue ₹24.02 Cr (FY 2023)).
Arun Sadhanandham was first appointed on 10 Jun 2019 as Director at Novacare Healthcare Solutions Private Limited. The most recent appointment on record is 20 Nov 2023 at Suraksha Diagnostic Limited.
The 3 current companies of Arun Sadhanandham that report revenue have a combined latest revenue of ₹7,125 Cr: Entero Healthcare Solutions Limited ₹6,610 Cr (FY 2026); Blue Sapphire Healthcares Private Limited ₹490 Cr (FY 2025); Lifewell Diagnostics Private Limited ₹24.02 Cr (FY 2023).
Arun Sadhanandham held 19 earlier board appointments: Suraksha Diagnostic Limited (Nominee Director, 20 Nov 2023 to 07 Jun 2025); H S Pathology Private Limited (Director, 05 Sep 2022 to 31 Jul 2024); Chethana Pharma Private Limited (Director, 06 Feb 2020 to 19 Oct 2023); Chethana Healthcare Solutions Private Limited (Director, 06 Feb 2020 to 19 Oct 2023); Novacare Healthcare Solutions Private Limited (Director, 10 Jun 2019 to 19 Oct 2023); and 14 more.
The current boards of Arun Sadhanandham's companies include Kaushik Balakrishnan Natesan (Entero Healthcare Solutions Limited), Prabhat Agrawal (Entero Healthcare Solutions Limited), Prabhat Agrawal (Entero Healthcare Solutions Limited), Prem Sethi (Entero Healthcare Solutions Limited), Sandhya Gadkari Sharma (Entero Healthcare Solutions Limited), Sanu Vishal Kapoor (Entero Healthcare Solutions Limited), among others.